February 16, 2018 / 9:53 PM / 4 months ago

BRIEF-U.S. FDA Expands Approval Of Imfinzi To Reduce The Risk Of Non-Small Cell Lung Cancer Progressing

Feb 16 (Reuters) - AstraZeneca Plc:

* U.S. FDA EXPANDS APPROVAL OF IMFINZI TO REDUCE THE RISK OF NON-SMALL CELL LUNG CANCER PROGRESSING

* FDA - GRANTED THE APPROVAL OF IMFINZI TO ASTRAZENECA‍​ Source text: (bit.ly/2EL2FKl) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below